News

Recursion Pharmaceuticals' $239M for AI drug discovery, optimize.health's $15.6M for remote patient monitoring and more digital health fundings
By Dave Muoio | 03:14 pm | September 10, 2020
Also: Skin Analytics' Series A contributes to AI-based detection of potential skin cancer; China's LickDoc supports its healthcare big data repository with $102 million.
With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, lo…
By Jonah Comstock | 11:54 am | September 10, 2020
Provider buy-in is more important than ever, digital therapeutics stakeholders say.
Femtech's sexual health revolution
By Laura Lovett | 11:52 am | September 10, 2020
Panelists at the HIMSS & Health 2.0 European Digital Conference discuss how digital health can help women learn more about their sexual health and wellbeing. 
The COVID-19 crisis has 'forced people into virtual mediums,' says CEO
By Kat Jercich | 06:12 pm | September 09, 2020
Bardy Diagnostics' founder hands off CEO role; Catapult Health looks inside for its new president; and more digital health hires and departures
By Dave Muoio | 03:47 pm | September 09, 2020
Also: Welldoc adds three new members to its executive team, and Uber Health loses its leader.
Veteran clinical navigation platform Grand Rounds raises $175M
By Laura Lovett | 03:01 pm | September 09, 2020
Truepill scores $75M in Series C funding and looks to roll out at-home testing services
By Laura Lovett | 02:11 pm | September 09, 2020
This news comes just months after it closed its $25 million Series B round. 
An untapped market for digital health innovation exists among seniors hoping to age in place
By Mallory Hackett | 01:35 pm | September 09, 2020
Ousted Zocdoc CEO accuses fellow cofounders and CFO of foul play in new lawsuit
By Dave Muoio | 01:28 pm | September 09, 2020
Filed yesterday, the suit describes a collaborative effort among Zocdoc executives and at least one investor to mislead the former CEO and chairman so that he could not protect himself from a sudden expulsion. 
AI beyond the buzz: 'The biggest element is the truth telling'
By Rosy Matheson | 11:49 am | September 09, 2020
There have been endless claims that AI will transform patient care, freeing up clinicians to spend time with patients and cutting costs, but many investors are wary of grandiose promises and prefer to hear the truth instead according to a session at the HIMSS & Health 2.0 European Digital Conference.